Akamai Technologies R&D increased by 1.5% to $141.58M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $123.55M to $141.58M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 11.2% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $77.26M | $82.90M | $93.17M | $99.94M | $92.07M | $94.05M | $105.38M | $91.86M | $99.04M | $105.94M | $109.20M | $116.93M | $113.35M | $120.35M | $120.25M | $123.55M | $125.84M | $124.72M | $139.45M | $141.58M |
| QoQ Change | — | +7.3% | +12.4% | +7.3% | -7.9% | +2.1% | +12.1% | -12.8% | +7.8% | +7.0% | +3.1% | +7.1% | -3.1% | +6.2% | -0.1% | +2.7% | +1.9% | -0.9% | +11.8% | +1.5% |
| YoY Change | — | — | — | — | +19.2% | +13.4% | +13.1% | -8.1% | +7.6% | +12.6% | +3.6% | +27.3% | +14.4% | +13.6% | +10.1% | +5.7% | +11.0% | +3.6% | +16.0% | +14.6% |